Sensorion appoints interim Chairman of the Board
Khalil Barrage has been a member of Sensorion's Board of Directors for over three years, and has lent his support to various fund-raising initiatives and his expertise to the company's specialization in gene therapy.
For almost twenty years, he has been Managing Director of the Invus Group, one of Sensorion's main shareholders. The company has initiated a search for a new Chairman and will inform the market in due course.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction